HCI Group remains fundamentally strong, with robust Q4 2025 growth and margins despite recent share price weakness. HCI's disciplined underwriting, risk-sharing with reinsurers, and prudent investment allocation underpin its resilience and profitability. Valuation is attractive, with HCI trading at 2.02x book value and 7x EPS, well below historical averages, supporting continued upside.